References
- Ahern, E., A. Cubitt, E. Ballard, M. W. L. Teng, W. C. Dougall, M. J. Smyth, D. Godbolt, R. Naidoo, A. Goldrick, and B. G. M. Hughes. 2019. Pharmacodynamics of pre-operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): Study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN). Trials 20 (1):753. doi:https://doi.org/10.1186/s13063-019-3951-x.
- Borg, R. V. D., A. Leonetti, M. Tiseo, E. Giovannetti, and G. J. Peters. 2019. Novel targeted strategies to overcome resistance in small-cell lung cancer: Focus on PARP inhibitors and rovalpituzumab tesirine. Expert Review of Anticancer Therapy 19 (6):461–71. doi:https://doi.org/10.1080/14737140.2019.1624530.
- Bothiraja, C., B. D. Yojana, A. P. Pawar, K. S. Shaikh, and U. H. Thorat. 2014. Fisetin-loaded nanocochleates: Formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opinion on Drug Delivery 11 (1):17–29. doi:https://doi.org/10.1517/17425247.2013.860131.
- Chougule, M. B., B. K. Padhi, and A. Misra. 2006. Nano-iposomal dry powder inhaler of amiloride hydrochloride. Journal of Nanoscience and Nanotechnology 6 (9):3001–9. In . doi:https://doi.org/10.1166/jnn.2006.405.
- Corti, G., M. Cirri, F. Maestrelli, N. Mennini, and P. Mura. 2008. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin. European Journal of Pharmaceutics and Biopharmaceutics 68 (2):303–9. doi:https://doi.org/10.1016/j.ejpb.2007.06.004.
- Dolatabadi, J. E. N., H. Hamishehkar, and H. Valizadeh. 2015. Development of dry powder inhaler formulation loaded with alendronate solid lipid anoparticles: Solid-state characterization and aerosol dispersion performance. Drug Development and Industrial Pharmacy 41 (9):1431–7. doi:https://doi.org/10.3109/03639045.2014.956111.
- Du, J., P. Du, and H. D. C. Smyth. 2013. Hydrogels for controlled pulmonary delivery. Therapeutic Delivery 4 (10):1293–305. doi:https://doi.org/10.4155/tde.13.90.
- Du, P., J. Du, and H. D. C. Smyth. 2014. Evaluation of granulated lactose as a carrier for DPI formulations 1: Effect of granule size. Ageing International 15 (6):1417–28. doi:https://doi.org/10.1208/s12249-014-0166-z.
- El-Gendy, N., and C. Berkland. 2009. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharmaceutical Research 26 (7):1752–63. doi:https://doi.org/10.1007/s11095-009-9886-2.
- Fornaro, T., B. Diletta, B. Malgorzata, and B. Vincenzo. 2015. Hydrogen-bonding effects on infrared spectra from anharmonic computations: uracil-water complexes and uracil dimers. Journal of Physical Chemistry A 119 (18):4224–36. doi:https://doi.org/10.1021/acs.jpca.5b01561.
- Gridelli, C., A. Rossi, P. Maione, E. Rossi, V. Castaldo, P. C. Sacco, and G. Colantuoni. 2009. Vascular disrupting agents: A novel mechanism of action in the battle against non‐small cell lung cancer. The Oncologist 14 (6):612–20. doi:https://doi.org/10.1634/theoncologist.2008-0287.
- Guan, Y., H. J. Shen, J. Shen, Y. L. Jia, X. W. Dong, Y. C. Jin, and Q. M. Xie. 2019. Anti-allergic activities of 5,7-dimethoxy-3,4′-dihydroxyflavone via inhalation in rat allergic models. European Journal of Pharmacology 848:55–61. doi:https://doi.org/10.1016/j.ejphar.2019.01.046.
- Gupta, V., N. Gupta, I. H. Shaik, R. Mehvar, I. F. Mcmurtry, M. Oka, E. Nozik-Grayck, M. Komatsu, and F. Ahsan. 2013. Liposomal fasudil, rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension. Journal of Controlled Release 167 (2):189–99. doi:https://doi.org/10.1016/j.jconrel.2013.01.011.
- Honmane, S., A. Hajare, H. More, R. A. M. Osmani, and S. Salunkhe. 2019. Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy. Journal of Liposome Research 29 (4):332–42. doi:https://doi.org/10.1080/08982104.2018.1531022.
- Huo, W., X. Zhang, K. Gan, Y. Chen, J. Xu, and J. Yang. 2019. Effect of zeta potential on properties of foamed colloidal suspension. Journal of the European Ceramic Society 39 (2–3):574–83. doi:https://doi.org/10.1016/j.jeurceramsoc.2018.08.035.
- Khatib, I., D. Khanal, J. Ruan, D. Cipolla, F. Dayton, J. D. Blanchard, and H. K. Chan. 2019. Ciprofloxacin nanocrystals liposomal powders or controlled drug release via inhalation. International Journal of Pharmaceutics 566:641–51. doi:https://doi.org/10.1016/j.ijpharm.2019.05.068.
- Landge, A., A. Pawar, and K. Shaikha. 2013. Investigation of cochleates as carriers for topical drug delivery. International Journal of Pharmacy and Harmaceutical Sciences 5 (2):314–20.
- Mali, A. J., C. Bothiraja, R. N. Purohit, and A. P. Pawar. 2017. In vitro and in vivo performance of novel spray dried andrographolide loaded scleroglucan based formulation for dry powder inhaler. Current Drug Delivery 14 (7):968–80. doi:https://doi.org/10.2174/1567201814666161109120455.
- Mali, A. J., A. P. Pawar, and C. Bothiraja. 2014. Improved lung delivery of budesonide from biopolymer based dry powder inhaler through natural inhalation of rat. Materials Technology 29 (6):350–7. doi:https://doi.org/10.1179/1753555714Y.0000000163.
- Mali, A. J., A. P. Pawar, and R. N. Purohit. 2014. Development of budesonide loaded biopolymer based dry powder inhaler: Optimization, in vitro deposition, and cytotoxicity study. Journal of Pharmaceutics 2014 2014:1–12. doi:https://doi.org/10.1155/2014/795371.
- Mehanna, M. M., S. M. Mohyeldin, and N. A. Elgindy. 2019. Rifampicin-carbohydrate spray-dried nanocomposite: A futuristic multiparticulate platform for pulmonary delivery. International Journal of Nanomedicine 14:9089–112. doi:https://doi.org/10.2147/IJN.S211182.
- Mehta, P. 2016. Dry powder inhalers: A focus on advancements. Journal of Drug Delivery 2016 2016:1–17. doi:https://doi.org/10.1155/2016/8290963.
- Mehta, P., C. Bothiraja, S. Kadam, and A. Pawar. 2018. Potential of dry powder inhalers for tuberculosis therapy: Facts, fidelity and future. Artificial Cells, Nanomedicine and Biotechnology 46 (sup3):S791–S806. doi:https://doi.org/10.1080/21691401.2018.1513938.
- Mehta, P., C. Bothiraja, S. Kadam, and A. Pawar. 2019. Effect of USP induction ports, glass sampling apparatus, and inhaler device resistance on aerodynamic patterns of fluticasone propionate–loaded engineered mannitol microparticles. AAPS PharmSciTech 20 (5):197. doi:https://doi.org/10.1208/s12249-019-1409-9.
- Muralidharan, P., D. Hayes, and H. M. Mansour. 2015. Dry powder inhalers in COPD, lung inflammation and pulmonary infections. Expert Opinion on Drug Delivery 12 (6):947–62. doi:https://doi.org/10.1517/17425247.2015.977783.
- Newman, S. P., D. Pavia, F. Moren, N. F. Sheahan, and S. W. Clarke. 1981. Deposition of pressurised aerosols in the human respiratory tract. Thorax 36 (1):52–5. doi:https://doi.org/10.1136/thx.36.1.52.
- Nounou, M. M., L. K. El-Khordagui, N. A. Khalafallah, and S. A. Khalil. 2006. In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharmaceutica 56 (3):311–24.
- Ota, K., T. Okuma, A. Lorenzo, A. Yokota, H. Hino, H. Kazama, S. Moriya, N. Takano, M. Hiramoto, and K. Miyazawa. 2019. Fingolimod sensitizes EGFR wild-type non-small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest. Oncology Reports 42 (1):231–42. doi:https://doi.org/10.3892/or.2019.7140.
- Park, S. Y., Z. Kang, P. Thapa, Y. S. Jin, J. W. Park, H. J. Lim, J. Y. Lee, S.-W. Lee, M.-H. Seo, M.-S. Kim, et al. 2019. Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach. International Journal of Pharmaceutics 566:229–38. doi:https://doi.org/10.1016/j.ijpharm.2019.05.064.
- Patil-Gadhe, A., and V. Pokharkar. 2014. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach. Pulmonary Pharmacology & Therapeutics 27 (2):197–207. doi:https://doi.org/10.1016/j.pupt.2013.07.006.
- Patil, S., A. Pawar, and S. Kumar. 2012. Effect of additives on the physicochemical and drug release properties of pioglitazone hydrochloride spherical agglomerates. Tropical Journal of Pharmaceutical Research 11:18–27.
- Pawar, A. P., A. P. Gholap, A. B. Kuchekar, C. Bothiraja, and A. J. Mali. 2015. Formulation and evaluation of optimized oxybenzone microsponge gel for topical delivery. Journal of Drug Delivery 2015:1–9. doi:https://doi.org/10.1155/2015/261068.
- Praveen, S., D. V. Gowda, A. Srivastava, and R. A. M. Osmani. 2016. Formulation and evaluation of nanostructured lipid carrier (NLC) for glimepiride. Der Pharmacia Lettre 8 (6):251–6.
- Qin, Q. P., Z. F. Wang, M. X. Tan, S. L. Wang, B. Q. Zou, D. M. Luo, i L. Qin, and S. H. Zhang. 2019. Two novel platinum(II) complexes with sorafenib and regorafenib: Synthesis, structural characterization, and evaluation of in vitro antitumor activity. Inorganic Chemistry Communications 104:27–30. doi:https://doi.org/10.1016/j.inoche.2019.03.031.
- Roeten, M. S. F., J. Cloos, and G. Jansen. 2018. Positioning of proteasome inhibitors in therapy of solid malignancies. Cancer Chemotherapy and Pharmacology 81 (2):227–43. doi:https://doi.org/10.1007/s00280-017-3489-0.
- Saint-Lorant, G., P. Leterme, A. Gayot, and M. P. Flament. 2007. Influence of carrier on the performance of dry powder inhalers. International Journal of Pharmaceutics 334 (1–2):85–91. doi:https://doi.org/10.1016/j.ijpharm.2006.10.028.
- Shaker, S., A. Gardouh, and M. Ghorab. 2017. Factors affecting liposomes particle size prepared by ethanol injection method. Research in Pharmaceutical Sciences 12 (5):346. doi:https://doi.org/10.4103/1735-5362.213979.
- Singh, M., and K. Lata. 2001. Randomized comparison ofa dry powder inhaler and metered dose inhaler with spacer in management of children with asthma. Indian Pediatrics 38 (1):24–8.
- Smola, M., T. Vandamme, and A. Sokolowski. 2008. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. International Journal of Nanomedicine 3 (1):1–19.
- Soema, P. C., G. J. Willems, W. Jiskoot, J. P. Amorij, and G. F. Kersten. 2015. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. European Journal of Pharmaceutics and Biopharmaceutics 94:427–35. doi:https://doi.org/10.1016/j.ejpb.2015.06.026.
- Teymouri Rad, R., S. Dadashzadeh, A. Vatanara, S. Alavi, E. Ghasemian, and S. A. Mortazavi. 2019. Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment. European Journal of Pharmaceutical Sciences: Sciences 133:275–86. doi:https://doi.org/10.1016/j.ejps.2019.04.001.
- Torrico Guzmán, E. A., S. Qihua, and S. A. Meenach. 2019. Development and evaluation of paclitaxel-loaded aerosol nanocomposite microparticles and their efficacy against air-grown lung cancer tumor spheroids. ACS Biomaterials Science and Engineering 5 (12):6570–80. doi:https://doi.org/10.1021/acsbiomaterials.9b00947.
- Tunki, L., H. Kulhari, L. N. Vadithe, M. Kuncha, S. Bhargava, D. Pooja, and R. Sistla. 2019. Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment. European Journal of Pharmaceutical Sciences 137:104978. doi:https://doi.org/10.1016/j.ejps.2019.104978.
- Viswanathan, V., R. Pharande, A. Bannalikar, P. Gupta, U. Gupta, and A. Mukne. 2019. Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: Formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies. Drug Development and Industrial Pharmacy 45 (1):11–20. doi:https://doi.org/10.1080/03639045.2018.1513025.
- Wang, J., S. Ma, X. Chen, S. Zhang, Z. Wang, and Q. Mei. 2019. The novel PI3K inhibitor S1 Synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling. Investigational New Drugs 37 (5):828–36. doi:https://doi.org/10.1007/s10637-018-0698-2.
- Yao, Y., W. Tianqi, L. Yongjun, and Z. Na. 2019. Co-delivery of sorafenib and VEGF-SiRNA via PH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma. Artificial Cells, Nanomedicine and Biotechnology 47 (1):1374–1383. doi:https://doi.org/10.1080/21691401.2019.1596943..
- Yardley, D. A. 2013. Nab-paclitaxel mechanisms of action and delivery. Journal of Controlled Release 170 (3):365–72. doi:https://doi.org/10.1016/j.jconrel.2013.05.041.
- Zhang, M. M., M. Li, Y. Y. Ge, T. T. Zhang, and Y. G. Jin. 2019. Liposomal melatonin dry powder inhalers for the treatment of primary lung cancer. Aoxue Xuebao 54 (3):555–64. doi:https://doi.org/10.16438/j.0513-4870.2018-1041.
- Zhang, T., Y. Chen, Y. Ge, Y. Hu, M. Li, and Y. Jin. 2018. Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers. Acta Pharmaceutica Sinica. B 8 (3):440–8. doi:https://doi.org/10.1016/j.apsb.2018.03.004.